CRYOPORT, INC. Machinery and Equipment, Gross
CRYOPORT, INC. (CYRX) had Machinery and Equipment, Gross of $19.76 million as of 2023-12-31, per its 10-K filed 2024-03-13.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:MachineryAndEquipmentGross · last filed 2024-03-13
- 2023-12-31: Machinery and Equipment, Gross $19.76M.
- 2022-12-31: Machinery and Equipment, Gross $16.49M.
- 2021-12-31: Machinery and Equipment, Gross $12.40M.
- 2020-12-31: Machinery and Equipment, Gross $10.93M; Machinery and Equipment, Gross as first filed $12.00M.
| Period end | Machinery and Equipment, Gross | Machinery and Equipment, Gross as first filed |
|---|---|---|
| 2023-12-31 | $19.76M 10-K · filed 2024-03-13 | |
| 2022-12-31 | $16.49M 10-K · filed 2024-03-13 | |
| 2021-12-31 | $12.40M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $10.93M 10-K · filed 2022-02-28 | $12.00M 10-K · filed 2021-03-01 |
| 2019-12-31 | $1.09M 10-K · filed 2021-03-01 | $1.09M 10-K · filed 2020-03-10 |
| 2018-12-31 | $567.51K 10-K · filed 2020-03-10 | |
| 2017-12-31 | $362.48K 10-K · filed 2019-03-13 | |
| 2016-12-31 | $310.40K 10-K · filed 2018-03-08 | |
| 2016-03-31 | $301.72K 10-KT · filed 2017-03-13 | |
| 2015-03-31 | $283.94K 10-K · filed 2016-06-28 | $350.52K 10-K · filed 2015-05-19 |
| 2014-03-31 | $386.73K 10-K · filed 2015-05-19 | |
| 2013-03-31 | $380.53K 10-K · filed 2014-06-25 | |
| 2012-03-31 | $377.92K 10-K · filed 2013-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |